Selvita completed the acquisition of PozLab for PLN25m.

Selvita, a drug discovery company, completed the acquisition of PozLab, a research and development center that provides pharmaceutic analytical services, for PLN25m. "I would like to extend a very warm welcome to our new colleagues in Poznan. It’s wonderful to have them on board and I am looking forward to all the synergies this new relationship will bring," Bogusław Sieczkowski, Selvita President of the Management Board.